Publications by authors named "Donna Vermes"

Claim this Profile
M
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial.
Edna B Foa, Helen Blair Simpson, Thea Gallagher, Michael G Wheaton, Marina Gershkovich, Donna Vermes

JAMA Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.
Helen B Simpson, Edna B Foa, Michael G Wheaton, Thea Gallagher, Marina Gershkovich, Donna Vermes

Behav Res Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion.
Carolyn I Rodriguez, Amanda Levinson, Jordana Zwerling, Donna Vermes, Helen Blair Simpson

J Clin Psychiatry· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.
Carolyn I Rodriguez, Lawrence S Kegeles, Amanda Levinson, R Todd Ogden, Xiangling Mao, Donna Vermes

Psychiatry Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
Franklin R Schneier, Raphael Campeas, Jaime Carcamo, Andrew Glass, Roberto Lewis-Fernandez, Donna Vermes

Depress Anxiety· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.
Edna B Foa, Helen Blair Simpson, David Rosenfield, Michael R Liebowitz, Shawn P Cahill, Donna Vermes

J Clin Psychiatry· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.
Carolyn I Rodriguez, Lawrence S Kegeles, Amanda Levinson, Tianshu Feng, Sue M Marcus, Donna Vermes

Neuropsychopharmacology· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Helen Blair Simpson, Edna B Foa, Michael R Liebowitz, Jonathan D Huppert, Shawn Cahill, Donna Vermes

JAMA Psychiatry· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability and predictors of first treatment contact for anxiety disorders in the United States: analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
Miren Iza, Mark Olfson, Donna Vermes, Marcela Hoffer, Shuai Wang

J Clin Psychiatry· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder.
Edna B Foa, Helen Blair Simpson, Michael R Liebowitz, Mark B Powers, David Rosenfield, Donna Vermes

J Clin Psychiatry· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.
Carlos Blanco, Richard G Heimberg, Franklin R Schneier, David M Fresco, Henian Chen, Donna Vermes

Arch Gen Psychiatry· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
Brian A Fallon, Eva Petkova, Natalia Skritskaya, Arturo Sanchez-Lacay, Franklin Schneier, Donna Vermes

J Clin Psychopharmacol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder.
Joshua D Lipsitz, Merav Gur, Donna Vermes, Eva Petkova, Jianfeng Cheng

Depress Anxiety· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Helen Blair Simpson, Edna B Foa, Michael R Liebowitz, Deborah Roth Ledley, Jonathan D Huppert, Donna Vermes

Am J Psychiatry· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults.
Randall D Marshall, Roberto Lewis-Fernandez, Carlos Blanco, H Blair Simpson, Shu-Hsing Lin, Donna Vermes

Depress Anxiety· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open pilot study of interpersonal psychotherapy for panic disorder (IPT-PD).
Joshua D Lipsitz, Merav Gur, Nina L Miller, Nicholas Forand, Donna Vermes

J Nerv Ment Dis· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open trial of fluvoxamine for hypochondriasis.
Brian A Fallon, Altamash I Qureshi, Franklin R Schneier, Arturo Sanchez-Lacay, Donna Vermes

Psychosomatics· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis